Navigation Links
Catheterization Recommended for Treating Pediatric Heart Conditions

DALLAS, May 2, 2011 /PRNewswire-USNewswire/ -- Doctors should consider using catheterization as a treatment tool in addition to its established role in diagnosing children with heart defects, according to a new American Heart Association scientific statement.  


A catheter is a thin flexible tube inserted into a blood vessel and used in procedures such as angiography, in which physicians use the catheter to inject dye into the arteries near the heart to illuminate the vessels via X-ray technology. It can also open a valve, enlarge a narrow blood vessel, close a hole in the heart or close off a blood vessel.

The statement, published in Circulation: Journal of the American Heart Association, is a major overhaul of the association's last statement released in 1998.

"What we can offer patients now, versus just 10 or 15 years ago, is remarkably different," said Timothy F. Feltes, M.D., lead author of the statement and chief of pediatric cardiology and professor of pediatrics at The Ohio State University. "There have been tremendous advances in the procedures, devices, experience and the expertise of the physicians who perform the procedures. As physicians caring for patients with congenital heart disease, we have to look at heart catheterizations a little differently than we have in the past."

The statement provides an extensive inventory of diagnostic and interventional techniques that are now considered as options for pediatric patients, noting that catherization procedures carry a degree of risk for patients.

Some of the 22 new therapeutic options for congenital heart disease include catheter-based techniques to: improve blood flow through the heart; repair inborn heart defects such as holes in the heart, repair or replace faulty valves; remove arterial blockages and many other conditions, such as malformed heart chambers.

In addition, the statement covers several hybrid procedures that use traditional surgical techniques in combination with catherization for treating conditions such as hypoplastic left heart syndrome (severe under development of the left side of the heart), stent implantation (to widen arteries and keep them open) and others.  

The take-home message of this statement, Feltes said, is that "there are numerous conditions that are best served by interventional catheterization procedures."

The statement is key to cardiologists who treat pediatric defects, because there are few other sources of such information. "By virtue of the relatively small number of children and adolescents with congenital heart disease, it is difficult to design clinical trials. Ideally, you need thousands of patients to compare one treatment versus another. Only one child in 100 is born with heart disease, so it is very unlikely that one center will have more than one patient to do a side-by-side comparison," Feltes said.

The Society for Cardiovascular Angiography and Interventions and the American Academy of Pediatrics endorsed the statement.

Co-authors are: Emile Bacha, M.D., chair; Robert H. Beekman III, M.D.; John P. Cheatham, M.D.; Jeffrey A. Feinstein, M.D., M.P.H.; Antoinette S. Gomes, M.D.; Ziyad M. Hijazi, M.D., M.P.H.; Frank F. Ing, M.D.; Michael de Moor, MB.BCh.; W. Robert Morrow, M.D.; Charles E. Mullins, M.D.; Kathryn A. Taubert, Ph.D. and Evan M. Zahn, M.D. Author disclosures are on the manuscript.

Additional resources:

NR11-1070 (Circ/Feltes)

Additional resources:

  • Downloadable stock footage, animation and our image gallery are located at under Multimedia.

Darcy Spitz: (212) 878-5940;
Bridgette McNeill: (214) 706-1135;
Julie Del Barto (broadcast): (214) 706-1330;

SOURCE American Heart Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BYDUREON™ Recommended for Approval in Europe
2. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
3. Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited
4. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
5. Half of All Women Do Not Get Regular Mammograms Despite Recommended Guidelines
6. Encisions Active Electrode Monitoring Technology Recommended at Minimally Invasive Gynecology Congress
7. DaTSCAN™ (Ioflupane I 123 Injection) Recommended in Updated European Guidelines for Diagnosis of Alzheimers Disease
8. Alaska EHR Alliance Selects e-MDs as Recommended Electronic Health Record Vendor
9. With 2009 H1N1 Cases on the Rise, New CDC-Recommended Vaccine Helps Protect Families Against Illness
10. Study Shows Lantus(R) Helped People Living with Type 2 Diabetes Reach the ADAs Recommended Target for Blood Sugar Control
11. ACR Supports American Cancer Society Inclusion of CT Colonography (Virtual Colonoscopy) as Recommended Screening Tool for Colorectal Cancer in New Screening Guidelines
Post Your Comments:
(Date:11/30/2015)... Nuance Communications, Inc. (NASDAQ: NUAN ) and ... today jointly announced a new integrated set of clinical ... College of Radiology,s (ACR) Imaging 3.0™ tools to enable ... current and emerging value-based payment models . ... clinical decision support, radiology reporting and image sharing technology ...
(Date:11/30/2015)... , Nov. 30, 2015  Novartis will demonstrate ... the 57 th American Society of Hematology (ASH) ... and myelomas as well as supportive care, including key ... to personalized cell therapies. The ASH Annual Meeting will ... . Novartis Oncology . "We will ...
(Date:11/30/2015)... IRVINE, Calif. and REHOVOT, Israel ... privately held specialty pharmaceutical company focused on acquiring and ... disorders, today announced the appointment of Keith A. ... directors. Gregory J. Flesher , chief executive ... experience in building successful organizations.  As chairman, he will ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... Holcomb – Kreithen ... plastic surgery practices in Florida, is proud to announce that Dr. Joshua Kreithen, ... giant Ethicon Inc., a Johnson & Johnson Company. , Ethicon is a global ...
(Date:11/30/2015)... EMIGSVILLE, PA (PRWEB) , ... November 30, 2015 ... ... (CCMS) software provider, has verified that their Vasont Universal Integrator (VUI) extension unites ... handle creating, editing, and managing content as a continuous process with the latest ...
(Date:11/30/2015)... Maryland (PRWEB) , ... November 30, 2015 , ... ... interactions could be of critical importance to the medical schools of the future. ... exhibited its healthcare suite at the 2015 ChangeMedEd conference in Chicago, organized by ...
(Date:11/30/2015)... ... 30, 2015 , ... Innovaacom, a leading provider of medical ... survey of educational needs for pharmacists worldwide. The poll of pharmacists in Europe, ... quality online and face-to-face education for pharmacists who are fast becoming the new ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... In 2016, expected coding changes are likely to include new codes for spine ... not easy to understand the effects of code changes in musculoskeletal, radiology and ...
Breaking Medicine News(10 mins):